✅ New API: 6000+ US Stock Options End-of-Day Data with 40+ fields. Learn more

Hinova Pharmaceuticals Inc. A (688302 SHG) stock market data APIs

¥56.2716 0.61(1.1%)
as of September 15, 2025
Try our APIs with free plan!

Hinova Pharmaceuticals Inc. A Financial Data Overview

Price chart is built with Anychart
ISIN: CNE10000**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Hinova Pharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and production of therapeutics for cancers and metabolic syndromes. It develops drugs based on proteolysis targeting chimera and deuteration technology. The company's products pipeline includes HC-1119, a product in phase III clinical trials with castration resistant prostate cancer indications; HP501, a product in phase II clinical trials for the treatment of hyperuricemia and gout; HP558, a product in phase II clinical trials to treat various late-stage cancers; and HP518, an oral PROTAC drug in phase I clinical trials with a focus on to solve the drug resistance of AR-mutated prostate cancer. Hinova Pharmaceuticals Inc. was founded in 2013 and is headquartered in Chengdu, China.

Prev. Close 56.2716
Open 56.8783
High 57.2079
Low 55.431
52 wk Range 25.33-71.98
Market Cap 5 592 M
Shares Outstanding 99 016 K
Revenue 13 424 K
EPS -0.7612
Beta 0.094

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Hinova Pharmaceuticals Inc. A data using free add-ons & libraries


Get Hinova Pharmaceuticals Inc. A Fundamental Data

Hinova Pharmaceuticals Inc. A Fundamental data includes:

  • Net Revenue: 13 424 K
  • EBITDA: -188 427 392
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Hinova Pharmaceuticals Inc. A Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2023-04-27
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Hinova Pharmaceuticals Inc. A End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat